CervoMed Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates

Reported positive Phase 2b RewinD-LB clinical data at CTAD 2025; additional analyses to be presented at AD/PD 2026 Obtained alignment with FDA and global regulators for planned Phase 3 trial design in ...
How-To Geek on MSN

Before the USB flash drive: 5 'floppy killers' that lost the retro storage war

Why Zip disks and LS-120s couldn't defeat the 1.44MB disk ...